Solis Women's Health Names Mano Mahadeva CFO

Solis Women's Health Names Mano Mahadeva CFO 
ADDISON, TX -- (Marketwire) -- 01/25/13 --   Solis Women's Health,
the nation's largest independent provider of screening and
diagnostics for breast cancer, is pleased to announce that Mano
Mahadeva, CPA, has been appointed Chief Financial Officer (CFO).  
Mr. Mahadeva will provide strategic operational planning support as
well as daily financial accountability, management and reporting as
Solis Women's Health continues to expand its nationwide network of
clinics devoted exclusively to the screening and diagnosis of breast
cancer, which currently serves over 500,000 patients in five states.  
"Mano has a strong track record of successfully driving growth
through sound fiscal planning and responsible financial management in
multi-location, alternative site (non-hospital) healthcare
companies," said Solis Chairman Matthew Witte. "We look forward to
the addition of his proven leadership skills as we continue to expand
our platform in existing and new markets with a particular focus on
partnering with major hospital systems in improving their continuum
of care in women's health."  
Prior to assuming the position of CFO at Solis, Mr. Mahadeva was the
Executive Director, North Texas Region, for U.S. Oncology Network, a
$3.6B division of Fortune 15 McKesson Corporation. Under Mr.
Mahadeva's leadership, the division grew from $300M to $360M in
annual revenue in the last five years, boasting a 25.4% profit
margin. In his 13 years at U.S. Oncology, Mr. Mahadeva also held the
positions of Regional Finance Director and Director, Corporate
Financial Planning. He has extensive experience in valuation and
investor relations, spearheading financial modeling and analysis
projects resulting in successful joint ventures with hospitals and
other partners. In addition, Mr. Mahadeva puts a priority on internal
and external client satisfaction as an indicator of overall business
health, and he is adept at deploying Lean Six Sigma as a key driver
behind business process initiatives. Prior to U.S. Oncology, Mr.
Mahadeva held positions of financial responsibility at Physician
Reliance Network, Texas Orthopedic Associates and Associated
Orthopedics and Sports Medicine, all in Texas.  
Mr. Mahadeva holds a Bachelor in Accounting from University of Te
Dallas, and an MBA in Management from Texas A&M University -
Commerce. He is a CPA, and holds ABV, CIA, CrFA, CGMA, CFF, CTP,
CITP, LREB, CFA (Level 3 Candidate), CMA, and CFM credentials.  
"Mano has a keen ability to understand and influence both the
business and financial needs of a growing company like ours," said
Solis CEO, James Polfreman. "His proven ability to work through the
challenges of acquisitions while never losing sight of service
quality nor revenue goals was a key factor in bringing Mano on board.
We will rely on Mano to help us more efficiently and effectively meet
our goals by allowing us to measure and gauge our performance with
detail we did not previously possess. We look forward to having him
on our team as we continue to offer exceptional breast care to women
With evidence that annual mammograms are effective in detecting
breast cancer in its earliest stages, Solis Women's Health was
established to provide the highest standard of care and services in a
positive atmosphere. The company was founded on the premise that by
focusing exclusively on the detection of breast cancer, employing
only experienced fellowship-trained breast physicians and utilizing
state-of-the-art digital equipment, it can produce significantly
better outcomes.  
Solis Women's Health is a specialized healthcare provider focused
exclusively on the screening and diagnosis of breast cancer.
Headquartered in Addison, Texas, Solis currently operates 20 clinics
in Dallas, Ft. Worth, Phoenix, Indianapolis, Columbus, Ohio; and
Greensboro, N.C. Solis provides a complete range of breast health
services including screening and diagnostic mammography,
computer-aided detection, breast ultrasound, automated breast
ultrasound, bone densitometry, stereotactic and ultrasound-guided
biopsy, breast specific gamma imaging and breast MRI. For more
information, visit  
Image Available: 
Media Contact 
Gregory M. Scott
Vice President, Business Development
Solis Women's Health
Office: 469.398.4107 
Press spacebar to pause and continue. Press esc to stop.